- New treatment for rare disease may prevent blindness
- Cure for age related blindness may be on the horizon
- Novel target to advance treatment of diabetic eye diseases
- And, about a dozen more articles about the science, medicine of and prevention of blindness
Editorial By Chris Hofstader
I thought this was an especially interesting week for the science and medicine involving blindness. There were a number of interesting studies published and I learned a lot of interesting things from this week's articles.
It is important for us to emphasize that WBH is a web site that intends to deliver as much of the news about the science and medicine related to blindness as we can in this digest. Nobody on our editorial team is an actual scientist. We do our best to not publish anything that is obviously pseudo-science or misinformation but, as we are not specialists, we want to make it very clear that you not try any intervention mentioned in any of the articles we publish here without first consulting a real ophthalmologist. Do not take medical advice from this or any other web site without discussing it first with a qualified medical professional.
Science and Medicine
A scientific seminar cum Christmas get-together to discuss eye diseases was organised here on Saturday under the joint aegis of Ranchi Ophthalmic Forum and Regional Institute of Ophthalmology, RIMS. The seminar saw the participation of over 100 ophthalmologists in the state. Dr Bharti Kashyap, secretary, Ranchi Ophthalmic Forum, coordinator of this scientific seminar cum Christmas meeting, started the programme with a welcome speech. This story comes to us from: Lagatar English.
If left untreated, glaucoma can cause irreversible blindness, which means that early detection and treatment are key to stopping vision loss. This story comes to us from: Yahoo Finance.
Analyse trends in incidence and aetiologies of childhood blindness … and prevention policies as well as promoting advancements in medical care. This story comes to us from: Nature.
Visual impairment and Blindness are more than just health concerns, as vision is typically not high on the priority list for many nations. This story comes to us from: MedTech Outlook.
Dr. Laroche is a glaucoma specialist who takes patient education seriously. He wants people to be aware that glaucoma, cataracts, macular degeneration and retinopathy can begin to surface between the ages of 40 and 70, and that any vision changes should be evaluated by your eye doctor immediately. This story comes to us from: Harlem World Magazine.
ANI): Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine. The randomized, double-blind, placebo-controlled trial was conducted by the department of surgery at Cedars-Sinai and at other medical centers nationwide. Thyroid eye disease is a rare and vision-threatening autoimmune condition that causes the muscles and fatty tissues behind the eye to become inflamed and enlarged, leading to bulging of the eyes. In addition to the bulging appearance, patients can experience double vision and light sensitivity. The disease can lead to blindness. This story comes to us from: ThePrint.
The days of simply accepting vision loss as just a part of the ageing process may soon be over after it was revealed scientists could be “one step closer” to developing a cure for age-related macular degeneration (AMD). This story comes to us from: Starts at 60
A recent study discovered a novel therapeutic target named ADAM10 that could be used to treat patients with Diabetic Retinopathy (DR), a condition that leads to blindness induced by prolonged diabetes. Abnormal blood vessel formation in the eyes of diabetic patients is a common phenomenon for DR, which could ultimately result in vision loss. This story comes to us from: Medical Xpress.
Diabetes can have devastating consequences for the eyes, resulting in blindness or visual impairment. This story comes to us from: Femina.in.
HelpMeSee, a global nonprofit that uses virtual reality and simulation-based training to eradicate cataract blindness, has announced a collaboration with Intel Corporation to accelerate its mission and increase access to sight-restoring surgery in developing countries. This story comes to us from: prnewswire.
Diabetes can have a serious negative impact on the eyes, which can result in blindness or visual impairment. This story comes to us from: India TV News.
Going blind forced columnist Dr. C to work on retraining his brain — a practice that has served him well in dealing with Parkinson's. This story comes to us from: Parkinson's News Today.
Blindness, the loss of vision, is becoming a public health concern as the World Health Organization (WHO) in 2019 estimated that about one billion people are living with preventable vision impairment globally. In Nigeria, research has shown that about 4.2 million adults above the age of 40 years have moderate to severe visual impairment or blindness. In other words, four out of every 100 adults over 40 have moderate or severe visual impairment in Nigeria. This story comes to us from: Leadership News.
ANI): Teprotumumab, a minimally invasive insulin-like growth factor I blocking antibody, has been shown to enhance symptoms, appearance, and quality of life in patients with thyroid eye disease, according to a study. The findings of the study were published in the New England Journal of Medicine. The randomized, double-blind, placebo-controlled trial was conducted by the department of surgery at Cedars-Sinai and at other medical centers nationwide. This story comes to us from: The Print.